Tocilizumab for the treatment of COVID-19: Evidence review of the clinical benefit and harm

Parrish, AReubenson, GBlockman, MCohen, KGray, AKredo, TDe Waal, RMaartens, GNel, JRees, H2025-01-092025-01-092021-05-26https://www.health.gov.za/wp-content/uploads/2021/06/Rapid-review-of-Tocilizumab-for-COVID-19-Update_28May2021.pdfhttps://hdl.handle.net/11288/598102Clinical evidence for the use of tocilizumab with or without other medicines in the management of hospitalised patients with severe COVID‐19 requiring oxygen or ventilatory assistance.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Tocilizumab for the treatment of COVID-19TocilizumabBenefit of tocilizumabClinical evidenceTocilizumab for the treatment of COVID-19: Evidence review of the clinical benefit and harmTechnical Report